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Background/aim: Tracheobronchomalacia (TBM) leads to the obstruction of expiratory airflow and interference with secretion
clearance. Stabilization of the airway wall using a silicon stent or laser coagulation of the posterior wall may be treatment options. This
study aimed to retrospectively analyze which interventional bronchoscopic method could be used to provide airway stabilization and
gain control of symptoms and for whom this method could be used.
Materials and methods: Fifteen patients who had received treatment in our interventional pulmonology unit were analyzed. We
analyzed the techniques used, stent duration, complications, and long-term treatment success retrospectively.
Results: Stents were used in 10 patients: 4 patients had silicon Y-stents and 4 patients had silicon tracheal stents. Stents were removed
due to early migration in 3 patients. In 5 of the 7 cases, the stent was removed due to frequent obstructions of the stent due to recurrent
severe mucostasis. A suitable stent was not found for one patient who had an extremely enlarged trachea. Good clinical results were
achieved in just two cases. The frequency of admissions to the emergency room and hospitalizations were diminished during the followup time in these two patients.
Conclusion: Silicon stents may be a good treatment option in selected patients with TBM and dynamic collapse. However, our patients
were high-risk; thus, the criteria for candidates for bronchoscopic treatment should be carefully defined.
Key words: Tracheobronchomalacia, interventional bronchoscopy, silicon stents, APC coagulation

1. Introduction
Tracheobronchomalacia (TBM) occurs due to the
degeneration of cartilaginous tissue and elastic fibers
of the main respiratory tract. The diameters of dynamic
airways decrease by 50% because of the excessive collapse
of the trachea and bronchi during expiration (1,2).
Dynamic airway collapse and TBM are different diseases
but both may be present in the same patient group (3).
Its prevalence in adults is unknown. TBM was found in
12% of patients who had bronchoscopies performed due
to respiratory pathologies (4,5), in 23% of COPD patients,
and in 44% of patients with chronic bronchitis (6).
Dynamic airway obstruction and air trapping may
occur with TBM. Except for the asymptomatic course,
TBM may also be confused with asthma or COPD;
therefore, a diagnosis cannot be established for all cases
(1,7). However, according to several extensive studies that
were conducted on the general population, the incidence
of TBM is thought to be 5%–10% (5,8).
* Correspondence: sedatural@yahoo.com

TBM is a dynamic condition; therefore, radiography
cannot be routinely used as a diagnostic method.
Computerized tomography and real-time spatialresolution three-dimensional reconstructions, especially
with a multidetector scanner, are ideal methods in
noninvasive scanning (9,10). Bronchoscopy is the gold
standard for defining dynamic airway collapse (1,3).
Although treatment is not necessary in patients who
are asymptomatic, determining the patients who are in
need of treatment is difficult. There is no specific approach
for TBM treatment (11,12). After treating symptoms of the
underlying pathology, continuous positive airway pressure
(CPAP) may be used, which functions as a pneumatic
stent that prevents the airway from collapsing (13).
Silicone stents may be used for stabilizing the airway as an
alternative treatment method (10,11,14). Fibrous cicatrix
formation and membrane stabilization can be achieved via
devascularization and coagulation of tissues with yttrium
aluminum garnet (YAG) laser treatment (15). For localized
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TBM cases, surgical techniques other than segmental
tracheal resection may be performed to strengthen the
cartilage wall or stabilize the posterior membrane (16,17).
In TBM treatment, as an interventional bronchoscopic
method, stents improve symptoms and respiratory
function by restoring the diameter of the airways. In our
study, we retrospectively analyzed which interventional
bronchoscopic method could be used to provide airway
stabilization and gain control of symptoms and for whom
this method could be used.
2. Materials and methods
2.1. Patients
We analyzed the records of 944 patients who underwent
rigid bronchoscopies under general anesthesia in our
interventional pulmonology unit between January 2005
and January 2013. Of these 944 patients, 15 patients had
TBM and underwent bronchoscopic treatment. These
patients were retrospectively investigated. Thirteen of the
patients with TBM had dyspnea as a cardinal symptom. The
patients underwent physical examinations and radiologic
and laboratory tests were undertaken. The anesthesia
department was consulted for rigid bronchoscopies that
were performed under general anesthesia and preoperative
preparations were completed. The patients gave informed
consent for the procedures.
2.2. Methods
All the patients were intubated using a rigid bronchoscope
(Efer Endoscopy, La Ciotat, France) under intravenous
general anesthesia using standard techniques and
mechanical debridement was performed when necessary.
2.3. Laser
Diode laser or argon plasma coagulation (APC) was used
during endobronchial treatment. A diode laser was used

for the endobronchial treatment at a wavelength of 980
nm with 4 to 25 W pulsed mode (Ceralas D 25; Biolitec,
Germany). APC (40 W, blended mode-continuous flow)
was performed using a device manufactured by ERBE
Elektromedizine GBMH (Germany). Standardized
protocols for appropriate power selections were used in
accordance with the manufacturer’s recommendations.
2.4. Cryotherapy
Cryotherapy was performed using the ERBOKRYO
system (Elektromedizine GBMH) when necessary over
the granulation tissue.
We evaluated procedural techniques, stent duration,
complications, and long-term treatment success. This is a
retrospective data analysis. No ethical statement is needed
in Turkey for studies in which there is a retrospective
analysis of standard diagnostic data.
Data were collected and analyzed by descriptive and
inferential statistics using MedCalc statistical software
(MedCalc 12.1; MedCalc Software, Belgium).
3. Results
Ten of our 15 patients were men and the mean age was
65.07 ± 13.19 years. Nine of the patients were smokers.
Thirteen patients (86.6%) had some comorbid diseases
(Table 1).
Fiber-optic bronchoscopy was used once in 5 patients,
twice in 3 patients, and four times in 1 patient in our patient
follow-ups. The number of patients who required further
rigid bronchoscopy under general anesthesia and the time
(days) between procedures are shown in Table 2. The
extensiveness and localization of TBM is shown in Table 3.
In attempts for treatment relative to the extent and locality
of TBM, Y-stents were used in 4 patients (Figure 1); silicon
stents were used in the trachea of 4 patients; a silicon stent

Table 1. Patient characteristics. DM: diabetes mellitus; COPD: chronic obstructive pulmonary disease; HT: hypertension, CHF:
congestive heart failure; overlap: obstructive sleep apnea syndrome + COPD.
Comorbid disease

Dyspnea

Smoking status

DM

COPD

HT

CHF

Malignancy

Overlap

+

-

+

-

1

6

5

2

1

1

12

3

9

6

Table 2. Number of procedures performed on patients and time between procedures in days; number of patients in need of ICU and
ICU admission period in days.
Number of
procedures

Number of
patients

1 time

11

Time between
procedures (days)

Number of
needs of ICU

Number of
patients

ICU admission
period (days)

1

3

7.6

2

1

4

3

1

27

3
2 times

3

4
98

3 times

438

1

8

120
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Table 3. Patient clinical characteristics. Right MB: right main bronchus. Left MB: left main bronchus.
Collapse extensiveness
Trachea
Total

Distal

9

4

Carina

Right MB

Left MB

5

8

7

Figure 1. Distal tracheal broncoscopic view of a patient before and after Y stent insertion

was used in the left main bronchus of 1 patient; a silicon
stent was used in the right main bronchus of 1 patient;
and no endobronchial treatment was used for 5 patients.
Posttreatment complications and their severities are
given in Table 4. Stents were removed in 2 patients during
follow-ups due to early migration. Stents were removed
in 5 of the 7 patients due to frequent obstructions of the
stent caused by recurrent severe mucostasis (Figure 2).
To provide coagulation to the tracheal posterior wall and
membrane stabilization, APC was performed in 1 patient.
Cryotherapy was used in 1 patient on the granulation
tissue that was formed in the distal segment of the stent.
A stent could not be used in 1 patient whose longitudinal

width was 45 mm because of the absence of adequately
sized stents. Patients who underwent endobronchial
treatment procedures were followed up in the intensive
care unit (Table 2). Follow-up durations of patients whose
stents were removed for various reasons are given in
Table 5. Stents were not removed for the purpose of TBM
treatment in 2 patients. No frequent admissions due to
COPD exacerbation and respiratory distress to emergency
rooms and hospitalizations were observed during the
follow-up time of these patients (1141 and 849 days).
One patient with a long-term stent who had no problems
during follow-up died from a nonpulmonary cause. One
patient is still under follow-up.

Table 4. Complications of patients with stent applications.
Complications
Mucostasis
Mild

Moderate

Severe

1

6

5

Migration
1

Granulation
Mild

Moderate

Severe

2

3

0

Figure 2. The appearance of a Y-stent after cleaning the mucus plug formed in the right and left leg which was placed in the
distal trachea.
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Table 5. Clinical follow-up data of patients with stent applications.
Location of stent application

Time period with stent (days)

Y-stent

880

Y-stent

125

Y-stent

6

Y-stent

6

Trachea

1245

Trachea

365

Left main bronchus

99

Right main bronchus

30

Figure 3. Patient’s radiograph before and after mucostasis cleaning.

4. Discussion
Determining the need for treatment in TBM patients and
lack of a distinctive treatment approach makes treatment
management more difficult. As mentioned before, previous
studies have reported the results of the different treatment
approaches for these patients. We evaluated 15 patients
with TBM in our series in terms of treatment and reviewed
the success rate of procedures with postprocedure followups. After application of stents, only two patients had longterm follow-ups due to complications of the procedures,
such as mucostasis, migration, and granulation. In patients
who were at risk before TBM surgery, endobronchial
treatment methods can be used as a tool for reducing
symptoms and finding the right treatment modality. There
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is a need for studies that include large numbers of patients
to show a high rate of success in selected cases.
CPAP is a noninvasive method that prevents airway
collapse, which may be considered after the symptoms of
TBM and concomitant conditions have been managed.
It reduces airway resistance and the energy spent on
respiration by keeping the airways open with positive
pressure. It is a method that can be both intermittently and
continuously used in patients who have mild symptoms
and who cannot be treated invasively. Surgical techniques
other than segmental tracheal resection may be performed
in patients with localized TBM to strengthen cartilage
walls or stabilize the posterior membrane. Considering
major and minor surgical complications, significant
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improvements can be made with symptoms, respiratory
parameters, and quality of life.
While there is no standard of care in the treatment
of TBM, silicon stent application appears to be a good
treatment for selected patients. Laser coagulation has also
shown the same success rate. In patients who have COPD,
asthma, or respiratory distress, procedures should be
performed while considering high risks and bronchoscopic
treatment criteria.
Ernst et al. prospectively investigated 75 patients in
their study and observed that neither the respiratory
function tests nor the 6-min walk test parameters showed
significant improvement at the end of the first month,
although there were significant improvements in terms
of symptoms and quality of life (10,11). In our study,
the number of presentations to emergency rooms and
hospitalizations due to respiratory distress of patients who
had permanent stents were significantly reduced; however,
there were a limited number of patients.
YAG lasers reach into the connective tissue and
submucosa and help fibrous cicatrix formation and
posterior membrane stabilization. Promising results were
achieved in a study conducted in Marseilles with diffuse
collapse or localized collapse in posterior side (18).
Prospective studies are needed to confirm the treatment
efficacy of YAG laser treatment.
Stents are another method of treatment; however,
there is no ideal stent available for airway stabilization
in invasive bronchoscopy. There are two types of stent:
metallic and silicon. Stents fix the diameters of airways.
The use of silicon stents improves the clinical symptoms

of TBM (19,20). Constant change in airway diameters in
TBM increases the risk of migration with silicon stents and
fracture with metallic stents. With both stent types there is
an increased risk of granuloma and mucus plug formation
at both ends of the stents and places where there is contact
with mucosa. Stents should be used in patients who have
severe symptoms, whose treatment-related complications
can be predicted, and who can be followed up with frequent
bronchoscopies. This treatment has inadequacies, such as
mucostasis formation at the distal segment of the stent
and stent migration (21,22). Mucostasis, migration, and
granulation tissue formation prompted stent removal in
most of the patients in our study and this shows the need
for large studies that include large numbers of participants.
In selected cases with TBM and dynamic airway
collapse, silicon stents appear to be the ideal treatment
method. Bronchoscopic procedures in selected patients
should be undertaken by experienced centers because
diagnosing TBM is difficult and patients who present
are in respiratory distress. Stents are used as a treatment
test in patients with severe symptoms who are candidates
for surgery to identify the benefits of fixing the airway
diameter and stabilization. Stents can be used as a
long-term palliative treatment in patients who have no
other treatment alternative if they provide significant
symptomatic improvement, provided that stent follow-up
and care are periodically undertaken.
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